Parkinson’s disease and related disorders such as dementia with Lewy bodies and multiple system atrophy…
Read MoreHealio covered recent research showing how CND Life Sciences’ Syn-One Test® detects a key neurodegenerative…
Read MoreVILAS Ventures, a healthcare-focused investment firm, announced its participation in the recent $13.5M Series A3…
Read MoreCND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and…
Read More
In the latest installment of our Patient Matters video series, Daryn Kagan talks with Bill…
Read MoreThe National Institutes of Health (NIH) has recognized the Syn-One Test as one of its…
Read MoreNeurologyLive covers recent findings showing the clinical utility of CND Life Sciences’ Syn-One Test–and how…
Read MoreThe Parkinson's Foundation published its Top Parkinson’s Science News Articles of 2024, featuring a study…
Read More
CND Life Sciences is conducting a clinical research study to learn more about the progression…
Read More
CND Life Sciences is continuing to add to its Syn-One Clinician Network, a directory of…
Read More
